Imagine a future where healthcare isn't just reactive but deeply personalized — where every patient gets the right treatment at the right time based on a precise understanding of their biology. This is the future Ovation is building, and on this week's Founded & Funded, Madrona Partner Chris Picardo dives into it all with Ovation CEO Curt Medeiros. From transforming underutilized clinical data into rich multiomics datasets to forging industry-leading partnerships with companies like Illumina, Curt shares how Ovation is shaping the future of precision medicine. He also opens up about the challenges of building a scalable, privacy-first platform, the lessons he's brought from leading large healthcare businesses, and why collaboration and diversity are key to solving complex problems in healthcare. Transcript: https://www.madrona.com/curt-medeiros-on-revolutionizing-precision-medicine-and-scaling-ovation Chapters:

Introduction

Ovation's Role in Precision Medicine

The Importance of Data in Precision Medicine

Challenges and Opportunities of Genomic Data

Privacy and Pharmaceutical Applications

Ovation's Unique Approach and Partnerships

Expanding Research Beyond Pharma

Recent Successes and Future Plans

Curt Medeiros' Journey to Ovation

Leadership Philosophy and Company Culture